However, follow-up studies with CD62L-/- NOD mice did not reveal any difference in diabetes induction between CD62L+/+ and CD62L-/- mice (76), suggesting that other mechanisms may be able to compensate for the lack of CD62L during diabetes development. The gene discussed is SELL; the disease is diabetes mellitus.